These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38524800)

  • 1. Selection of the optimal personalized treatment from multiple treatments with right-censored multivariate outcome measures.
    Siriwardhana C; Kulasekera KB; Datta S
    J Appl Stat; 2024; 51(5):891-912. PubMed ID: 38524800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Personalized Treatment Selection with Multivariate Outcome Measures in a Multiple Treatment Case.
    Siriwardhana C; Kulasekera KB
    Commun Stat Simul Comput; 2023; 52(12):5773-5787. PubMed ID: 38371330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of the optimal personalized treatment from multiple treatments with multivariate outcome measures.
    Siriwardhana C; Datta S; Kulasekera KB
    J Biopharm Stat; 2020 May; 30(3):462-480. PubMed ID: 31691633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Response Based Personalized Treatment Selection with Data from Crossover Designs for Multiple Treatments.
    Kulasekera KB; Siriwardhana C
    Commun Stat Simul Comput; 2022; 51(2):554-569. PubMed ID: 35299995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized treatment plans with multivariate outcomes.
    Siriwardhana C; Kulasekera KB
    Biom J; 2020 Dec; 62(8):1973-1985. PubMed ID: 32627863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantiles based personalized treatment selection for multivariate outcomes and multiple treatments.
    Kulasekera KB; Siriwardhana C
    Stat Med; 2022 Jul; 41(15):2695-2710. PubMed ID: 35699385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model selection for survival individualized treatment rules using the jackknife estimator.
    Honvoh GD; Cho H; Kosorok MR
    BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation with interval censored data and covariates.
    Van der Laan MJ; Hubbard A
    Lifetime Data Anal; 1997; 3(1):77-91. PubMed ID: 9384627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation in optimal treatment regimes based on mean residual lifetimes with right-censored data.
    Liu Z; Zhan Z; Lin C; Zhang B
    Biom J; 2023 Dec; 65(8):e2200340. PubMed ID: 37789592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tree based weighted learning for estimating individualized treatment rules with censored data.
    Cui Y; Zhu R; Kosorok M
    Electron J Stat; 2017; 11(2):3927-3953. PubMed ID: 29403568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules.
    Eaton AA; Zabor EC
    Stat Med; 2022 Apr; 41(9):1599-1612. PubMed ID: 35043427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A probability based method for selecting the optimal personalized treatment from multiple treatments.
    Siriwardhana C; Zhao M; Datta S; Kulasekera KB
    Stat Methods Med Res; 2019 Mar; 28(3):749-760. PubMed ID: 29145777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous marginal survival estimators when doubly censored data is present.
    Julià O; Gómez G
    Lifetime Data Anal; 2011 Jul; 17(3):347-72. PubMed ID: 20886370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
    Hsu CH; Taylor JM; Hu C
    Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Cox regression models for composite time-to-event endpoints with component-wise censoring in randomized trials.
    Speiser JL; Ambrosius WT; Pajewski NM
    Clin Trials; 2023 Oct; 20(5):507-516. PubMed ID: 37243355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weighted Kaplan-Meier estimators motivating to estimate HIV-1 RNA reduction censored by a limit of detection.
    Ahmed I; Flandre P
    Stat Med; 2020 Mar; 39(7):968-983. PubMed ID: 31981243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparametric regression with right-censored covariate via conditional density function.
    Jiang H; Huang L; Xia Y
    Stat Med; 2022 May; 41(11):2025-2051. PubMed ID: 35124839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression modeling of restricted mean survival time for left-truncated right-censored data.
    Rong R; Ning J; Zhu H
    Stat Med; 2022 Jul; 41(16):3003-3021. PubMed ID: 35708238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.